[1]
|
Yan, H.M., Zhao, H.J., Guo, D.Y., Zhu, P.Q., Zhang, C.L. and Jiang, W. (2018) Gut Microbiota Alterations in Moderate to Severe Acne Vulgaris Patients. The Journal of Dermatology, 45, 1166-1171. https://doi.org/10.1111/1346-8138.14586
|
[2]
|
Juhl, C.R., Bergholdt, H.K., Miller, I.M., Jemec, G.B., Kanters, J.K. and Ellervik, C. (2018) Dairy Intake and Acne Vulgaris: A Systematic Review and Meta-Analysis of 78,529 Children, Adolescents, and Young Adults. Nutrients, 10, Article No. 1049. https://doi.org/10.3390/nu10081049
|
[3]
|
Dréno, B., Pécastaings, S., Corvec, S., Veraldi, S., Khammari, A. and Roques, C. (2018) Cutibacterium acnes (Propionibacterium acnes) and Acne Vulgaris: A Brief Look at the Latest Updates. Journal of the European Academy of Dermatology and Venereology, 32, 5-14. https://doi.org/10.1111/jdv.15043
|
[4]
|
Hay, R.J., Johns, N.E., Williams, H.C., Bolliger, I.W., Dellavalle, R.P., Margolis, D.J., et al. (2014) The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions. Journal of Investigative Dermatology, 134, 1527-1534. https://doi.org/10.1038/jid.2013.446
|
[5]
|
George, R.M. and Sridharan, R. (2018) Factors Aggravating or Precipitating Acne in Indian Adults: A Hospital-Based Study of 110 Cases. Indian Journal of Dermatology, 63, 328-331. https://doi.org/10.4103/ijd.IJD_565_17
|
[6]
|
Chen, H.Y., Lin, Y.H. and Chen, Y.C. (2016) Identifying Chinese Herbal Medicine Network for Treating Acne: Implications from a Nationwide Database. Journal of Ethnopharmacology, 179, 1-8. https://doi.org/10.1016/j.jep.2015.12.032
|
[7]
|
Hazarika, N. and Archana, M. (2016) The Psychosocial Impact of Acne Vulgaris. Indian Journal of Dermatology, 61, 515-520. https://doi.org/10.4103/0019-5154.190102
|
[8]
|
Ak, M. (2019) A Comprehensive Review of Acne Vulgaris. The Journal of Clinical Pharmacology, 1, 17-45.
|
[9]
|
Alexeyev, O.A., Dekio, I., Layton, A.M., Li, H., Hughes, H., Morris, T., et al. (2018) Why We Continue to Use the Name Propionibacterium acnes. British Journal of Dermatology, 179, 1227. https://doi.org/10.1111/bjd.17085
|
[10]
|
Motosko, C., Zakhem, G., Pomeranz, M. and Hazen, A. (2019) Acne: A Side-Effect of Masculinizing Hormonal Therapy in Transgender Patients. British Journal of Dermatology, 180, 26-30. https://doi.org/10.1111/bjd.17083
|
[11]
|
Eyüboglu, M., Kalay, I. and Eyüboglu, D. (2018) Evaluation of Adolescents Diagnosed with Acne Vulgaris for Quality of Life and Psychosocial Challenges. Indian Journal of Dermatology, 63, 131-135.
|
[12]
|
Zaenglein, A.L., Pathy, A.L., Schlosser, B.J., Alikhan, A., Baldwin, H.E., Berson, D.S., et al. (2016) Guidelines of Care for the Management of Acne Vulgaris. Journal of the American Academy of Dermatology, 74, 945-973.E33. https://doi.org/10.1016/j.jaad.2015.12.037
|
[13]
|
Nast, A., Dreno, B., Bettoli, V., Degitz, K., Erdmann, R., Finlay, A., et al. (2012) European Evidence-Based (S3) Guidelines for the Treatment of Acne. Journal of the European Academy of Dermatology and Venereology, 26, 1-29. https://doi.org/10.1111/j.1468-3083.2011.04374.x
|
[14]
|
Meredith, F.M. and Ormerod, A.D. (2013) The Management of Acne Vulgaris in Pregnancy. American Journal of Clinical Dermatology, 14, 351-358. https://doi.org/10.1007/s40257-013-0041-9
|
[15]
|
Fulton Jr., J.E., Farzad-Bakshandeh, A. and Bradley, S. (1974) Studies on the Mechanism of Action of Topical Benzoyl Peroxide and Vitamin A Acid in Acne Vulgaris. Journal of Cutaneous Pathology, 1, 191-200. https://doi.org/10.1111/j.1600-0560.1974.tb00628.x
|
[16]
|
Shalita, A.R., Rafal, E.S., Anderson, D.N., Yavel, R., Landow, S. and Lee, W. (2003) Compared Efficacy and Safety of Tretinoin 0.1% Microsphere Gel Alone and in Combination with Benzoyl Peroxide 6% Cleanser for the Treatment of Acne Vulgaris. Cutis, 72, 167-172.
|
[17]
|
Tanghetti, E., Abramovits, W., Solomon, B., Loven, K. and Shalita, A. (2006) Tazarotene Versus Tazarotene Plus Clindamycin/Benzoyl Peroxide in the Treatment of Acne Vulgaris: A Multicenter, Double-Blind, Randomized Parallel-Group Trial. Journal of Drugs in Dermatology: JDD, 5, 256-261.
|
[18]
|
Del Rosso, J.Q. (2007) Study Results of Benzoyl Peroxide 5%/Clindamycin 1% Topical Gel, Adapalene 0.1% Gel, and Use in Combination for Acne Vulgaris. Journal of Drugs in Dermatology: JDD, 6, 616-622.
|
[19]
|
Tanghetti, E.A. and Popp, K.F. (2009) A Current Review of Topical Benzoyl Peroxide: New Perspectives on Formulation and Utilization. Dermatologic Clinics, 27, 17-24. https://doi.org/10.1016/j.det.2008.07.001
|
[20]
|
Del Rosso, J.Q., Baldwin, H., Keri, J., Mancini, A., Gold, L.S. and Webster, G.F. (2009) Current Approach to Acne Management: A Community-Based Analysis. Cutis, 83, 5-21.
|
[21]
|
Mills Jr., O., Thornsberry, C., Cardin, C.W., Smiles, K.A. and Leyden, J.J. (2002) Bacterial Resistance and Therapeutic Outcome Following Three Months of Topical Acne Therapy with 2% Erythromycin Gel versus Its Vehicle. Acta Dermato-Venereologica, 82, 260-265. https://doi.org/10.1080/000155502320323216
|
[22]
|
Cunliffe, W.J., Holland, K.T., Bojar, R. and Levy, S.F. (2002) A Randomized, Double-Blind Comparison of a Clindamycin Phosphate/Benzoyl Peroxide Gel Formulation and a Matching Clindamycin Gel with Respect to Microbiologic Activity and Clinical Efficacy in the Topical Treatment of Acne Vulgaris. Clinical Therapeutics, 24, 1117-1133. https://doi.org/10.1016/S0149-2918(02)80023-6
|
[23]
|
Becker, L.E., Bergstresser, P.R., Whiting, D.A., Clendenning, W.E., Dobson, R.L., Jordan, W.P., et al. (1981) Topical Clindamycin Therapy for Acne Vulgaris: A Cooperative Clinical Study. Archives of Dermatology, 117, 482-485. https://doi.org/10.1001/archderm.1981.01650080036024
|
[24]
|
Kuhlman, D. and Callen, J. (1986) A Comparison of Clindamycin Phosphate 1 Percent Topical Lotion and Placebo in the Treatment of Acne Vulgaris. Cutis, 38, 203-206.
|
[25]
|
Leyden, J.J., Shalita, A.R., Saatjian, G.D. and Sefton, J. (1987) Erythromycin 2% Gel in Comparison with Clindamycin Phosphate 1% Solution in Acne Vulgaris. Journal of the American Academy of Dermatology, 16, 822-827. https://doi.org/10.1016/S0190-9622(87)70107-8
|
[26]
|
Shalita, A.R., Smith, E.B. and Bauer, E. (1984) Topical Erythromycin V Clindamycin Therapy for Acne: A Multicenter, Double-Blind Comparison. Archives of Dermatology, 120, 351-355. https://doi.org/10.1001/archderm.120.3.351
|
[27]
|
Gollnick, H., Cunliffe, W., Berson, D., Dreno, B., Finlay, A., Leyden, J., Global Alliance to Improve Outcomes in Acne, et al. (2003) Management of Acne: A Report from a Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology, 49, S1-S37. https://doi.org/10.1067/mjd.2003.618
|
[28]
|
Krishnan, G. (1976) Comparison of Two Concentrations of Tretinoin Solution in the Topical Treatment of Acne Vulgaris. The Practitioner, 216, 106-109.
|
[29]
|
Lucky, A.W., Cullen, S.I., Funicella, T., Jarratt, M.T., Jones, T. and Reddick, M.E. (1998) Double-Blind, Vehicle-Controlled, Multicenter Comparison of Two 0.025% Tretinoin Creams in Patients with Acne Vulgaris. Journal of the American Academy of Dermatology, 38, S24-S30. https://doi.org/10.1016/S0190-9622(98)70142-2
|
[30]
|
Peachey, R. and Connor, B. (1971) Topical Retinoic Acid in the Treatment of Acne Vulgaris. British Journal of Dermatology, 85, 462-466. https://doi.org/10.1111/j.1365-2133.1971.tb14054.x
|
[31]
|
Shalita, A., Chalker, D., Griffith, R., Herbert, A., Hickman, J., Maloney, J., et al. (1999) Tazarotene Gel Is Safe and Effective in the Treatment of Acne Vulgaris: A Multicenter, Double-Blind, Vehicle-Controlled Study. Cutis, 63, 349-354.
|
[32]
|
Panchaud, A., Csajka, C., Merlob, P., Schaefer, C., Berlin, M., De Santis, M., et al. (2012) Pregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospective Study. The Journal of Clinical Pharmacology, 52, 1844-1851. https://doi.org/10.1177/0091270011429566
|
[33]
|
Loureiro, K.D., Kao, K.K., Jones, K.L., Alvarado, S., Chavez, C., Dick, L., et al. (2005) Minor Malformations Characteristic of the Retinoic Acid Embryopathy and Other Birth Outcomes in Children of Women Exposed to Topical Tretinoin during Early Pregnancy. American Journal of Medical Genetics Part A, 136, 117-121. https://doi.org/10.1002/ajmg.a.30744
|
[34]
|
Kolli, S.S., Pecone, D., Pona, A., Cline, A. and Feldman, S.R. (2019) Topical Retinoids in Acne Vulgaris: A Systematic Review. American Journal of Clinical Dermatology, 20, 345-365. https://doi.org/10.1007/s40257-019-00423-z
|
[35]
|
Habeshian, K.A. and Cohen, B.A. (2020) Current Issues in the Treatment of Acne Vulgaris. Pediatrics, 145, S225-S230. https://doi.org/10.1542/peds.2019-2056L
|
[36]
|
Schulte, B.C., Wu, W. and Rosen, T. (2015) Azelaic Acid: Evidence-Based Update on Mechanism of Action and Clinical Application. Journal of Drugs in Dermatology: JDD, 14, 964-968.
|
[37]
|
Kircik, L.H. (2011) Efficacy and Safety of Azelaic Acid (Aza) Gel 15% in the Treatment of Post-Inflammatory Hyperpigmentation and Acne: A 16-Week, Baseline-Controlled Study. Journal of Drugs in Dermatology: JDD, 10, 586-590.
|
[38]
|
Hashim, P.W., Chen, T., Harper, J.C. and Kircik, L.H. (2018) The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Facial Acne Vulgaris. Journal of Drugs in Dermatology: JDD, 17, 641-645.
|
[39]
|
Hoffman, L.K., Del Rosso, J.Q. and Kircik, L.H. (2017) The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris. Journal of Drugs in Dermatology: JDD, 16, 534-538.
|
[40]
|
Marson, J.W. and Baldwin, H.E. (2019) An Overview of Acne Therapy, Part 1: Topical Therapy, Oral Antibiotics, Laser and Light Therapy, and Dietary Interventions. Dermatologic Clinics, 37, 183-193. https://doi.org/10.1016/j.det.2018.12.001
|
[41]
|
Pickert, A. and Raimer, S. (2009) An Evaluation of Dapsone Gel 5% in the Treatment of Acne Vulgaris. Expert Opinion on Pharmacotherapy, 10, 1515-1521. https://doi.org/10.1517/14656560903002097
|
[42]
|
Draelos, Z.D., Carter, E., Maloney, J.M., Elewski, B., Poulin, Y., Lynde, C., et al. (2007) Two Randomized Studies Demonstrate the Efficacy and Safety of Dapsone Gel, 5% for the Treatment of Acne Vulgaris. Journal of the American Academy of Dermatology, 56, 439.E1-439.E10. https://doi.org/10.1016/j.jaad.2006.10.005
|
[43]
|
Del Rosso, J.Q., Kircik, L. and Gallagher, C.J. (2015) Comparative Efficacy and Tolerability of Dapsone 5% Gel in Adult versus Adolescent Females with Acne Vulgaris. The Journal of Clinical and Aesthetic Dermatology, 8, 31-37.
|
[44]
|
Tanghetti, E., Harper, J.C. and Oefelein, M.G. (2012) The Efficacy and Tolerability of Dapsone 5% Gel in Female Vs Male Patients with Facial Acne Vulgaris: Gender as a Clinically Relevant Outcome Variable. Journal of Drugs in Dermatology: JDD, 11, 1417-1421.
|
[45]
|
Jarratt, M., Bucko, A., Grekin, S., Berlin, J., Bukhalo, M., Weiss, J., et al. (2016) Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults with Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials. Journal of Drugs in Dermatology: JDD, 15, 553-561.
|
[46]
|
Jarratt, M.T., Jones, T.M., Chang-Lin, J.E., Tong, W., Berk, D.R., Lin, V., et al. (2016) Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris. Journal of Drugs in Dermatology: JDD, 15, 1250-1259.
|
[47]
|
Lebrun, C.M. (2004) Rosac Cream with Sunscreens (Sodium Sulfacetamide 10% and Sulfur 5%). SKINmed: Dermatology for the Clinician, 3, 92. https://doi.org/10.1111/j.1540-9740.2004.03465.x
|
[48]
|
Tarimci, N., Sener, S. and Kilinc, T. (1997) Topical Sodium Sulfacetamide/Sulfur Lotion. Journal of Clinical Pharmacy and Therapeutics, 22, 301-302. https://doi.org/10.1046/j.1365-2710.1997.9975099.x
|
[49]
|
Elstein, W. (1981) Topical Deodorized Polysulfides. Broadscope Acne Therapy. Cutis, 28, 468-472.
|
[50]
|
Hjorth, N., Storm, D. and Dela, K. (1985) Topical Anhydrous Aluminum Chloride Formulation in the Treatment of Acne Vulgaris: A Double-Blind Study. Cutis, 35, 499-500.
|
[51]
|
Cochran, R.J., Tucker, S.B. and Flannigan, S.A. (1985) Topical Zinc Therapy for Acne Vulgaris. International Journal of Dermatology, 24, 188-190. https://doi.org/10.1111/j.1365-4362.1985.tb05425.x
|
[52]
|
Khodaeiani, E., Fouladi, R.F., Amirnia, M., Saeidi, M. and Karimi, E.R. (2013) Topical 4% Nicotinamide vs. 1% Clindamycin in Moderate Inflammatory Acne Vulgaris. International Journal of Dermatology, 52, 999-1004. https://doi.org/10.1111/ijd.12002
|
[53]
|
Thiboutot, D.M., Dréno, B., Abanmi, A., Alexis, A.F., Araviiskaia, E., Cabal, M.I.B., et al. (2018) Practical Management of Acne for Clinicians: An International Consensus from the Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology, 78, S1-S23.E1. https://doi.org/10.1016/j.jaad.2017.09.078
|
[54]
|
Walsh, T.R., Efthimiou, J. and Dréno, B. (2016) Systematic Review of Antibiotic Resistance in Acne: An Increasing Topical and Oral Threat. The Lancet Infectious Diseases, 16, E23-E33. https://doi.org/10.1016/S1473-3099(15)00527-7
|
[55]
|
Perret, L.J. and Tait, C.P. (2014) Non-Antibiotic Properties of Tetracyclines and Their Clinical Application in Dermatology. Australasian Journal of Dermatology, 55, 111-118. https://doi.org/10.1111/ajd.12075
|
[56]
|
Henehan, M., Montuno, M. and De Benedetto, A. (2017) Doxycycline as an Anti-Inflammatory Agent: Updates in Dermatology. Journal of the European Academy of Dermatology and Venereology, 31, 1800-1808. https://doi.org/10.1111/jdv.14345
|
[57]
|
Fleischer Jr., A.B., Dinehart, S., Stough, D. and Plott, R.T. (2006) Safety and Efficacy of a New Extended-Release Formulation of Minocycline. Cutis, 78, 21-31.
|
[58]
|
Eichenfield, L.F., Krakowski, A.C., Piggott, C., Del Rosso, J., Baldwin, H., Friedlander, S.F., et al. (2013) Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne. Pediatrics, 131, S163-S186. https://doi.org/10.1542/peds.2013-0490B
|
[59]
|
Andriessen, A. and Lynde, C.W. (2014) Antibiotic Resistance: Shifting the Paradigm in Topical Acne Treatment. Journal of Drugs in Dermatology: JDD, 13, 1358-1364.
|
[60]
|
Huang, Y.C. and Cheng, Y.C. (2017) Isotretinoin Treatment for Acne and Risk of Depression: A Systematic Review and Meta-Analysis. Journal of the American Academy of Dermatology, 76, 1068-1076.E9. https://doi.org/10.1016/j.jaad.2016.12.028
|
[61]
|
Costa, C.S., Bagatin, E., Martimbianco, A.L.C., da Silva, E.M., Lúcio, M.M., Magin, P., et al. (2018) Oral Isotretinoin for Acne. Cochrane Database of Systematic Reviews, 11, CD009435. https://doi.org/10.1002/14651858.CD009435.pub2
|
[62]
|
Werner, C.A., Papic, M.J., Ferris, L.K., Lee, J.K., Borrero, S., Prevost, N., et al. (2014) Women’s Experiences with Isotretinoin Risk Reduction Counseling. JAMA Dermatology, 150, 366-371. https://doi.org/10.1001/jamadermatol.2013.6862
|
[63]
|
Speroff, L. and DeCherney, A. (1993) Evaluation of a New Generation of Oral Contraceptives. The Advisory Board for the New Progestins. Obstetrics and Gynecology, 81, 1034-1047.
|
[64]
|
Marynick, S.P., Chakmakjian, Z.H., McCaffree, D.L. and Herndon Jr., J.H. (1983) Androgen Excess in Cystic Acne. New England Journal of Medicine, 308, 981-986. https://doi.org/10.1056/NEJM198304283081701
|
[65]
|
Faloia, E., Filipponi, S., Mancini, V., Morosini, P. and De Pirro, R. (1993) Treatment with a Gonadotropin-Releasing Hormone Agonist in Acne or Idiopathic Hirsutism. Journal of Endocrinological Investigation, 16, 675-677. https://doi.org/10.1007/BF03348907
|
[66]
|
Lee, J.K. and Smith, A.D. (2017) Metformin as an Adjunct Therapy for the Treatment of Moderate to Severe Acne Vulgaris. Dermatology Online Journal, 23, Article ID: 13030. https://doi.org/10.5070/D32311037242
|
[67]
|
Ulvestad, M., Bjertness, E., Dalgard, F. and Halvorsen, J. (2017) Acne and Dairy Products in Adolescence: Results from a Norwegian Longitudinal Study. Journal of the European Academy of Dermatology and Venereology, 31, 530-535. https://doi.org/10.1111/jdv.13835
|
[68]
|
Aghasi, M., Golzarand, M., Shab-Bidar, S., Aminianfar, A., Omidian, M. and Taheri, F. (2019) Dairy Intake and Acne Development: A Meta-Analysis of Observational Studies. Clinical Nutrition, 38, 1067-1075. https://doi.org/10.1016/j.clnu.2018.04.015
|